Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. Moolman

Acne is a common skin disease that affects the follicular unit of the skin. Inflammatory- and noninflammatory forms of acne exist. The most affected areas on the body include the face, upper part of the chest and the back. These are the areas with the most sebaceous follicles. Acne occurs when hyper...

Full description

Bibliographic Details
Main Author: Moolman, Judith Margaretha
Published: North-West University 2011
Subjects:
Online Access:http://hdl.handle.net/10394/3987
id ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-3987
record_format oai_dc
spelling ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-39872014-04-16T03:56:06ZFormulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. MoolmanMoolman, Judith MargarethaAzelaic acidNiacinamideTransdermal diffusionStability testingPheroidTMAcne is a common skin disease that affects the follicular unit of the skin. Inflammatory- and noninflammatory forms of acne exist. The most affected areas on the body include the face, upper part of the chest and the back. These are the areas with the most sebaceous follicles. Acne occurs when hyperkeratinisation causes the cells of the hair follicle to shed too fast. These cells then block the follicle opening. Thus, sebum cannot pass through the hair follicle onto the skin. The human skin is composed of three layers, namely the epidermis, which acts as a waterproof layer and a barrier to infections; the dermis, which contains the skin appendages; and the subcutaneous fat layer. Skin acts as a protective layer against pathogens and damage to the body. It also provides a semi-impermeable barrier to prevent water loss. Azelaic acid and niacinamide are both currently used in the treatment of acne. Azelaic acid is a saturated dicarboxylic acid which is used to treat mild to moderate acne. It has antibacterial, keratolytic and comedolytic properties. Niacinamide, on the other hand, is the amide of nicotinic acid and is beneficial in the treatment of both papular and pustular acne. It has a demonstrated anti-inflammatory action and causes dose-dependent inhibition of sebocyte secretions. The Pheroid™ delivery system is a colloidal system that consists of even lipid-based submicron-and micron-sized structures that are very unique in nature. This technology is able to improve the absorption and/or efficacy of various active ingredients, as well as other compounds. In this study, a cream, Pheroid™ cream, a gel and a Pheroid™ gel were formulated, containing both azelaic acid and niacinamide. Stability tests were conducted on these formulations for six months, and it was established that none of the formulations were stable under the different storage conditions. Tests that were conducted during stability testing, as determined by the Medicines Control Council, included: assay, mass variation, appearance, viscosity, pH determination and confocal laser scanning microscopy (CLSM). Diffusion studies (12 hours long in total) with vertical Franz cells were conducted with Caucasian female skin obtained after abdominoplastic surgery. Tape-stripping followed in order to establish the epidermis and dermis concentrations of azelaic acid and niacinamide. Significant concentrations of both active ingredients were found in the epidermis and the dermis after 12 hours.Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2010.North-West University2011-02-23T14:02:48Z2011-02-23T14:02:48Z2010Thesishttp://hdl.handle.net/10394/3987
collection NDLTD
sources NDLTD
topic Azelaic acid
Niacinamide
Transdermal diffusion
Stability testing
PheroidTM
spellingShingle Azelaic acid
Niacinamide
Transdermal diffusion
Stability testing
PheroidTM
Moolman, Judith Margaretha
Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. Moolman
description Acne is a common skin disease that affects the follicular unit of the skin. Inflammatory- and noninflammatory forms of acne exist. The most affected areas on the body include the face, upper part of the chest and the back. These are the areas with the most sebaceous follicles. Acne occurs when hyperkeratinisation causes the cells of the hair follicle to shed too fast. These cells then block the follicle opening. Thus, sebum cannot pass through the hair follicle onto the skin. The human skin is composed of three layers, namely the epidermis, which acts as a waterproof layer and a barrier to infections; the dermis, which contains the skin appendages; and the subcutaneous fat layer. Skin acts as a protective layer against pathogens and damage to the body. It also provides a semi-impermeable barrier to prevent water loss. Azelaic acid and niacinamide are both currently used in the treatment of acne. Azelaic acid is a saturated dicarboxylic acid which is used to treat mild to moderate acne. It has antibacterial, keratolytic and comedolytic properties. Niacinamide, on the other hand, is the amide of nicotinic acid and is beneficial in the treatment of both papular and pustular acne. It has a demonstrated anti-inflammatory action and causes dose-dependent inhibition of sebocyte secretions. The Pheroid™ delivery system is a colloidal system that consists of even lipid-based submicron-and micron-sized structures that are very unique in nature. This technology is able to improve the absorption and/or efficacy of various active ingredients, as well as other compounds. In this study, a cream, Pheroid™ cream, a gel and a Pheroid™ gel were formulated, containing both azelaic acid and niacinamide. Stability tests were conducted on these formulations for six months, and it was established that none of the formulations were stable under the different storage conditions. Tests that were conducted during stability testing, as determined by the Medicines Control Council, included: assay, mass variation, appearance, viscosity, pH determination and confocal laser scanning microscopy (CLSM). Diffusion studies (12 hours long in total) with vertical Franz cells were conducted with Caucasian female skin obtained after abdominoplastic surgery. Tape-stripping followed in order to establish the epidermis and dermis concentrations of azelaic acid and niacinamide. Significant concentrations of both active ingredients were found in the epidermis and the dermis after 12 hours. === Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2010.
author Moolman, Judith Margaretha
author_facet Moolman, Judith Margaretha
author_sort Moolman, Judith Margaretha
title Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. Moolman
title_short Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. Moolman
title_full Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. Moolman
title_fullStr Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. Moolman
title_full_unstemmed Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / J.M. Moolman
title_sort formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide / j.m. moolman
publisher North-West University
publishDate 2011
url http://hdl.handle.net/10394/3987
work_keys_str_mv AT moolmanjudithmargaretha formulationinvitroreleaseandtransdermaldiffusionofazelaicacidwithtopicalniacinamidejmmoolman
_version_ 1716664957751263232